Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NBR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101928762 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPS8L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SENP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CABLES2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEMA3F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABCD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASB16-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPOX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP2A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATG16L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IP6K2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYO15B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DXO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSTD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on